Page 7 of the AGM shows nearer term revenue drivers with BOTH a global consumer healthcare company & their TGA approved manufacturer.
"In 2013, Imugene has extended its Linguet technology
to the Consumer Healthcare Market with a ’meltlet’ for:
• Vitamins, Supplements and Nutraceuticals
– vitamins specifically vitamin D (development
complete and currently being commercialised),
minerals and herbal ranges;
– In November 2013, Imugene has entered into an
R&D project with a Global Consumer Healthcare
company and their TGA approved manufacturer
(both unnamed for confidentiality and competition
reasons);
– First right of refusal to exclusively license results
and products created;
– Vitamins and supplements industry is big business
in Australia, worth an estimated $1.5bn each year;
– The industry is growing at up to 12% annually."
- Forums
- ASX - By Stock
- 10c target in 12 month
Page 7 of the AGM shows nearer term revenue drivers with BOTH a...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.7¢ | 5.8¢ | 5.6¢ | $1.040M | 18.27M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1917207 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 653942 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1917207 | 0.056 |
14 | 3386705 | 0.055 |
25 | 3644629 | 0.054 |
15 | 2901167 | 0.053 |
19 | 1811203 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 653942 | 7 |
0.059 | 3329802 | 11 |
0.060 | 1565197 | 16 |
0.061 | 2979688 | 13 |
0.062 | 332268 | 4 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |